Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X.

J Natl Cancer Inst. 1998 Mar 4;90(5):358-63.

PMID:
9498485
2.

D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study.

Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR.

Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1021-6.

3.

[Study on the association between smoking behavior and dopamine receptor D2 gene polymorphisms among lung cancer cases].

Qi J, Tan W, Xing D, Miao X, Lin D.

Zhonghua Liu Xing Bing Xue Za Zhi. 2002 Oct;23(5):370-3. Chinese.

PMID:
12482370
4.

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.

Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):453-8.

5.

Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumption.

Wernicke C, Reese J, Kraschewski A, Winterer G, Rommelspacher H, Gallinat J.

Pharmacopsychiatry. 2009 Mar;42(2):41-50. doi: 10.1055/s-0028-1085444. Epub 2009 Mar 23.

PMID:
19308877
6.

The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.

Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.

Mov Disord. 2000 Jan;15(1):127-31.

PMID:
10634251
7.

DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers.

Radwan GN, El-Setouhy M, Mohamed MK, Hamid MA, Azem SA, Kamel O, Israel E, Loffredo CA.

Nicotine Tob Res. 2007 Dec;9(12):1325-9.

PMID:
18058350
8.

The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls.

Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS.

Behav Genet. 2010 Jan;40(1):49-58. doi: 10.1007/s10519-009-9301-0. Epub 2009 Oct 15.

9.

Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence.

Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J, Skowronek MH, Schumann G.

J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):673-81. doi: 10.1097/CHI.0b013e31816bff77.

PMID:
18434921
10.

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.

Oliveri RL, Annesi G, Zappia M, Civitelli D, Montesanti R, Branca D, Nicoletti G, Spadafora P, Pasqua AA, Cittadella R, Andreoli V, Gambardella A, Aguglia U, Quattrone A.

Neurology. 1999 Oct 22;53(7):1425-30.

PMID:
10534246
11.

Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.

Lee HS, Kim SH, Lee HJ, Kim L, Lee SK, Jang DW, Lee MS, Son BG, Suh KY, Kim S.

Am J Med Genet. 2002 Aug 8;114(6):593-7.

PMID:
12210271
12.
13.

Evidence suggesting the role of specific genetic factors in cigarette smoking.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG.

Health Psychol. 1999 Jan;18(1):14-20.

PMID:
9925041
14.

Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphism.

Connor JP, Young RM, Lawford BR, Saunders JB, Ritchie TL, Noble EP.

Addict Behav. 2007 Feb;32(2):310-9.

PMID:
16766132
15.

GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Bernges U, Philipp M, Woitowitz HJ.

Cancer Lett. 2004 May 10;208(1):65-74.

PMID:
15105047
17.

Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.

Vandenbergh DJ, O'Connor RJ, Grant MD, Jefferson AL, Vogler GP, Strasser AA, Kozlowski LT.

Addict Biol. 2007 Mar;12(1):106-16.

PMID:
17407504
18.

No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.

Anghelescu I, Germeyer S, Müller MJ, Klawe C, Singer P, Dahmen N, Wetzel H, Himmerich H, Szegedi A.

Alcohol Clin Exp Res. 2001 Jun;25(6):805-9.

PMID:
11410714
19.

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.

Cinciripini P, Wetter D, Tomlinson G, Tsoh J, De Moor C, Cinciripini L, Minna J.

Nicotine Tob Res. 2004 Apr;6(2):229-39.

PMID:
15203796
20.

Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.

Goetz CG, Burke PF, Leurgans S, Berry-Kravis E, Blasucci LM, Raman R, Zhou L.

Arch Neurol. 2001 Feb;58(2):209-13.

PMID:
11176958

Supplemental Content

Support Center